| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 63 | 2023 | 4584 | 4.960 |
Why?
|
| Cardiac Surgical Procedures | 43 | 2022 | 3537 | 4.480 |
Why?
|
| Fontan Procedure | 15 | 2022 | 778 | 2.630 |
Why?
|
| Cardiopulmonary Bypass | 23 | 2021 | 1066 | 2.450 |
Why?
|
| Thrombelastography | 7 | 2021 | 164 | 2.300 |
Why?
|
| Oximetry | 9 | 2020 | 471 | 2.110 |
Why?
|
| Anesthesia | 16 | 2022 | 1561 | 1.970 |
Why?
|
| Erythrocyte Transfusion | 7 | 2022 | 565 | 1.750 |
Why?
|
| Surgical Procedures, Operative | 13 | 2022 | 1876 | 1.750 |
Why?
|
| Postoperative Complications | 28 | 2023 | 15295 | 1.740 |
Why?
|
| Oxygen | 20 | 2019 | 4189 | 1.470 |
Why?
|
| Hypnotics and Sedatives | 8 | 2019 | 1162 | 1.400 |
Why?
|
| Hirudins | 4 | 2024 | 183 | 1.390 |
Why?
|
| Pediatrics | 11 | 2022 | 3475 | 1.310 |
Why?
|
| Hypoplastic Left Heart Syndrome | 7 | 2022 | 574 | 1.300 |
Why?
|
| Milrinone | 4 | 2021 | 84 | 1.270 |
Why?
|
| Anesthetics | 5 | 2023 | 539 | 1.260 |
Why?
|
| Anesthesia, General | 9 | 2022 | 1171 | 1.210 |
Why?
|
| Child | 99 | 2023 | 77709 | 1.200 |
Why?
|
| Thoracic Surgery | 3 | 2022 | 719 | 1.180 |
Why?
|
| Infant | 79 | 2023 | 35136 | 1.150 |
Why?
|
| Hospital Mortality | 15 | 2022 | 5317 | 1.110 |
Why?
|
| Oxyhemoglobins | 6 | 2020 | 216 | 1.070 |
Why?
|
| Pulmonary Circulation | 6 | 2019 | 739 | 1.020 |
Why?
|
| Perioperative Care | 10 | 2021 | 1002 | 1.000 |
Why?
|
| Cardiac Output | 8 | 2019 | 854 | 0.980 |
Why?
|
| Blood Transfusion | 10 | 2019 | 1301 | 0.970 |
Why?
|
| Blood Loss, Surgical | 6 | 2018 | 662 | 0.970 |
Why?
|
| Extracorporeal Membrane Oxygenation | 8 | 2019 | 1354 | 0.920 |
Why?
|
| Fibrinogen | 3 | 2016 | 894 | 0.910 |
Why?
|
| Neuromuscular Blockade | 2 | 2016 | 146 | 0.900 |
Why?
|
| Analgesia | 3 | 2016 | 461 | 0.860 |
Why?
|
| Child, Preschool | 65 | 2022 | 41006 | 0.860 |
Why?
|
| Infant, Newborn | 58 | 2023 | 25625 | 0.850 |
Why?
|
| Heparin | 3 | 2024 | 1637 | 0.850 |
Why?
|
| Anesthesiology | 4 | 2022 | 1060 | 0.850 |
Why?
|
| Hemodynamics | 14 | 2022 | 4199 | 0.840 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2021 | 45 | 0.800 |
Why?
|
| Hospital Costs | 3 | 2017 | 985 | 0.790 |
Why?
|
| Conscious Sedation | 7 | 2015 | 528 | 0.780 |
Why?
|
| Spectroscopy, Near-Infrared | 5 | 2020 | 721 | 0.770 |
Why?
|
| Hydrogen | 1 | 2021 | 164 | 0.760 |
Why?
|
| Bronchitis | 1 | 2021 | 201 | 0.750 |
Why?
|
| Midazolam | 2 | 2021 | 270 | 0.750 |
Why?
|
| Hematocrit | 4 | 2017 | 636 | 0.750 |
Why?
|
| Dexmedetomidine | 3 | 2010 | 315 | 0.740 |
Why?
|
| Humans | 198 | 2024 | 744343 | 0.730 |
Why?
|
| Factor VIIa | 2 | 2019 | 101 | 0.730 |
Why?
|
| Heart Bypass, Right | 3 | 2018 | 74 | 0.720 |
Why?
|
| Hyperoxia | 2 | 2019 | 262 | 0.710 |
Why?
|
| Heart Ventricles | 9 | 2022 | 3821 | 0.700 |
Why?
|
| Professional Practice | 1 | 2022 | 326 | 0.700 |
Why?
|
| Lymphatic Diseases | 1 | 2021 | 324 | 0.700 |
Why?
|
| Hemostasis | 2 | 2021 | 458 | 0.690 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2019 | 66 | 0.680 |
Why?
|
| Critical Care | 7 | 2022 | 2647 | 0.680 |
Why?
|
| Thrombosis | 8 | 2019 | 2968 | 0.670 |
Why?
|
| Anemia | 3 | 2017 | 1506 | 0.660 |
Why?
|
| Adsorption | 1 | 2019 | 201 | 0.660 |
Why?
|
| Echocardiography | 8 | 2023 | 5102 | 0.650 |
Why?
|
| Surgical Mesh | 1 | 2021 | 276 | 0.650 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 2023 | 209 | 0.640 |
Why?
|
| Pleural Effusion | 1 | 2021 | 338 | 0.630 |
Why?
|
| Echocardiography, Transesophageal | 7 | 2018 | 1133 | 0.630 |
Why?
|
| Williams Syndrome | 2 | 2018 | 187 | 0.610 |
Why?
|
| Heart-Assist Devices | 4 | 2019 | 1194 | 0.610 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 851 | 0.590 |
Why?
|
| Analgesics | 3 | 2019 | 1040 | 0.570 |
Why?
|
| Tranexamic Acid | 2 | 2015 | 146 | 0.560 |
Why?
|
| Preoperative Care | 6 | 2021 | 2250 | 0.560 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1972 | 0.550 |
Why?
|
| Craniosynostoses | 3 | 2016 | 401 | 0.540 |
Why?
|
| Antifibrinolytic Agents | 2 | 2015 | 254 | 0.540 |
Why?
|
| Oxygen Consumption | 6 | 2018 | 1869 | 0.530 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 2016 | 130 | 0.530 |
Why?
|
| Heart Arrest | 6 | 2022 | 1470 | 0.520 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 687 | 0.520 |
Why?
|
| Anesthesia, Caudal | 1 | 2015 | 25 | 0.510 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2019 | 342 | 0.500 |
Why?
|
| Intraoperative Complications | 3 | 2018 | 1198 | 0.490 |
Why?
|
| Operating Rooms | 3 | 2022 | 817 | 0.490 |
Why?
|
| Retrospective Studies | 53 | 2023 | 77449 | 0.490 |
Why?
|
| Reading | 1 | 2018 | 558 | 0.480 |
Why?
|
| Hospitals, Pediatric | 9 | 2021 | 1775 | 0.480 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2018 | 1422 | 0.480 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2023 | 1186 | 0.470 |
Why?
|
| Heart | 9 | 2021 | 4467 | 0.470 |
Why?
|
| Hospitalization | 6 | 2023 | 10262 | 0.460 |
Why?
|
| Coronary Circulation | 4 | 2016 | 1572 | 0.460 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 761 | 0.450 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2018 | 454 | 0.450 |
Why?
|
| Heart Failure | 4 | 2023 | 10900 | 0.450 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2016 | 478 | 0.450 |
Why?
|
| Blood Gas Analysis | 3 | 2019 | 383 | 0.440 |
Why?
|
| Pulmonary Atresia | 2 | 2017 | 160 | 0.440 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 1643 | 0.430 |
Why?
|
| Blood Coagulation | 5 | 2021 | 1127 | 0.420 |
Why?
|
| Heart Transplantation | 4 | 2016 | 3110 | 0.420 |
Why?
|
| Male | 93 | 2022 | 350118 | 0.420 |
Why?
|
| Length of Stay | 10 | 2022 | 6309 | 0.420 |
Why?
|
| Bradycardia | 3 | 2009 | 307 | 0.420 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2009 | 57 | 0.420 |
Why?
|
| Inpatients | 3 | 2023 | 2518 | 0.410 |
Why?
|
| Incidence | 18 | 2021 | 20947 | 0.410 |
Why?
|
| Databases, Factual | 14 | 2022 | 7729 | 0.410 |
Why?
|
| Pulmonary Artery | 7 | 2020 | 1912 | 0.400 |
Why?
|
| Body Temperature | 1 | 2015 | 777 | 0.400 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 977 | 0.390 |
Why?
|
| Societies, Medical | 3 | 2018 | 3743 | 0.390 |
Why?
|
| Hypothermia, Induced | 3 | 2015 | 752 | 0.390 |
Why?
|
| Goals | 1 | 2016 | 706 | 0.390 |
Why?
|
| Female | 88 | 2022 | 380194 | 0.380 |
Why?
|
| Consensus | 3 | 2023 | 2959 | 0.380 |
Why?
|
| Respiration, Artificial | 4 | 2018 | 2569 | 0.370 |
Why?
|
| Treatment Outcome | 33 | 2024 | 63114 | 0.370 |
Why?
|
| Recombinant Proteins | 6 | 2024 | 6622 | 0.340 |
Why?
|
| Catheterization, Central Venous | 3 | 2019 | 514 | 0.340 |
Why?
|
| Glycopyrrolate | 1 | 2009 | 33 | 0.340 |
Why?
|
| Risk Factors | 29 | 2023 | 72290 | 0.340 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2008 | 30 | 0.330 |
Why?
|
| Hemostasis, Surgical | 1 | 2009 | 128 | 0.330 |
Why?
|
| Adolescent | 42 | 2023 | 85781 | 0.330 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2018 | 1536 | 0.320 |
Why?
|
| Peptide Fragments | 4 | 2024 | 5097 | 0.320 |
Why?
|
| Models, Theoretical | 3 | 2017 | 3589 | 0.320 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 215 | 0.320 |
Why?
|
| Jugular Veins | 2 | 2017 | 204 | 0.310 |
Why?
|
| Equipment Design | 5 | 2021 | 3582 | 0.310 |
Why?
|
| Phenoxybenzamine | 1 | 2007 | 54 | 0.310 |
Why?
|
| Head-Down Tilt | 1 | 2007 | 64 | 0.300 |
Why?
|
| Heart Septum | 1 | 2008 | 313 | 0.300 |
Why?
|
| Quality Improvement | 4 | 2019 | 3749 | 0.300 |
Why?
|
| Postoperative Nausea and Vomiting | 2 | 2020 | 119 | 0.300 |
Why?
|
| Valsalva Maneuver | 1 | 2007 | 92 | 0.300 |
Why?
|
| Nervous System | 1 | 2010 | 554 | 0.300 |
Why?
|
| Pain | 3 | 2018 | 4986 | 0.300 |
Why?
|
| Transposition of Great Vessels | 2 | 2022 | 588 | 0.300 |
Why?
|
| Postoperative Period | 5 | 2020 | 1842 | 0.290 |
Why?
|
| Risk Assessment | 18 | 2023 | 23338 | 0.290 |
Why?
|
| Aortic Coarctation | 2 | 2023 | 281 | 0.290 |
Why?
|
| Atrial Function, Left | 1 | 2008 | 173 | 0.280 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 2073 | 0.280 |
Why?
|
| Hypertension, Pulmonary | 4 | 2022 | 1537 | 0.280 |
Why?
|
| Antithrombins | 2 | 2019 | 304 | 0.280 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 346 | 0.270 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2018 | 981 | 0.270 |
Why?
|
| Ventricular Function | 3 | 2018 | 416 | 0.270 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3158 | 0.260 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2291 | 0.260 |
Why?
|
| Platelet Activation | 1 | 2009 | 673 | 0.260 |
Why?
|
| Coronary Care Units | 2 | 2016 | 214 | 0.250 |
Why?
|
| Protamines | 2 | 2018 | 106 | 0.240 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.240 |
Why?
|
| Biomedical Research | 1 | 2020 | 3309 | 0.240 |
Why?
|
| Ventricular Fibrillation | 1 | 2007 | 538 | 0.240 |
Why?
|
| Anesthetics, Inhalation | 3 | 2018 | 570 | 0.240 |
Why?
|
| Palliative Care | 5 | 2017 | 3493 | 0.240 |
Why?
|
| Cerebrovascular Circulation | 5 | 2019 | 2731 | 0.230 |
Why?
|
| Thrombocytopenia | 2 | 2009 | 1179 | 0.230 |
Why?
|
| Blood Preservation | 2 | 2018 | 177 | 0.230 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 314 | 0.230 |
Why?
|
| Mitral Valve | 2 | 2018 | 1491 | 0.220 |
Why?
|
| Medication Errors | 1 | 2009 | 798 | 0.220 |
Why?
|
| Survival Rate | 7 | 2021 | 12788 | 0.220 |
Why?
|
| Stroke Volume | 1 | 2016 | 5007 | 0.220 |
Why?
|
| Reoperation | 5 | 2022 | 4201 | 0.220 |
Why?
|
| Perioperative Period | 3 | 2020 | 256 | 0.210 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2022 | 1541 | 0.210 |
Why?
|
| Coronary Artery Bypass | 1 | 2012 | 2289 | 0.210 |
Why?
|
| Clinical Competence | 1 | 2018 | 4687 | 0.210 |
Why?
|
| Anticoagulants | 3 | 2024 | 4599 | 0.210 |
Why?
|
| Postoperative Hemorrhage | 3 | 2018 | 413 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2015 | 3209 | 0.200 |
Why?
|
| Isoflurane | 4 | 2021 | 380 | 0.200 |
Why?
|
| Lung | 3 | 2018 | 9856 | 0.190 |
Why?
|
| Infant, Premature | 2 | 2021 | 2044 | 0.190 |
Why?
|
| Erythrocytes | 2 | 2022 | 2455 | 0.190 |
Why?
|
| Stethoscopes | 1 | 2021 | 28 | 0.190 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2019 | 980 | 0.190 |
Why?
|
| United States | 12 | 2023 | 69872 | 0.190 |
Why?
|
| Atrial Septum | 1 | 2021 | 60 | 0.190 |
Why?
|
| Hemorrhage | 3 | 2021 | 3461 | 0.190 |
Why?
|
| Drug and Narcotic Control | 1 | 2001 | 146 | 0.190 |
Why?
|
| Cardiac Output, Low | 1 | 2021 | 195 | 0.180 |
Why?
|
| Hypertension | 3 | 2010 | 8480 | 0.180 |
Why?
|
| Fentanyl | 2 | 2021 | 410 | 0.180 |
Why?
|
| Lymphatic System | 1 | 2021 | 253 | 0.180 |
Why?
|
| Hypoxia, Brain | 1 | 2020 | 133 | 0.180 |
Why?
|
| Child Development | 2 | 2010 | 2223 | 0.180 |
Why?
|
| Models, Biological | 2 | 2019 | 9583 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15540 | 0.170 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2022 | 269 | 0.170 |
Why?
|
| Thermodilution | 1 | 2019 | 52 | 0.170 |
Why?
|
| Thrombophilia | 2 | 2017 | 305 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2019 | 35421 | 0.170 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2017 | 76 | 0.170 |
Why?
|
| Heart Valve Prosthesis | 1 | 2008 | 1488 | 0.170 |
Why?
|
| Blood Coagulation Factors | 4 | 2007 | 355 | 0.170 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 390 | 0.160 |
Why?
|
| Massage | 1 | 2018 | 85 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2009 | 2508 | 0.160 |
Why?
|
| Monitoring, Intraoperative | 3 | 2010 | 957 | 0.160 |
Why?
|
| Adult | 27 | 2023 | 214055 | 0.160 |
Why?
|
| Respiratory Dead Space | 1 | 2018 | 30 | 0.160 |
Why?
|
| Platelet Transfusion | 2 | 2018 | 314 | 0.160 |
Why?
|
| Embolism, Air | 2 | 2016 | 111 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 3068 | 0.150 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 379 | 0.150 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2018 | 134 | 0.150 |
Why?
|
| Marijuana Abuse | 1 | 2001 | 403 | 0.150 |
Why?
|
| Cyanosis | 1 | 2017 | 83 | 0.150 |
Why?
|
| Sternotomy | 1 | 2018 | 121 | 0.150 |
Why?
|
| Tachycardia | 1 | 2020 | 619 | 0.150 |
Why?
|
| Heart Function Tests | 2 | 2016 | 330 | 0.150 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2016 | 11 | 0.150 |
Why?
|
| Heart Diseases | 2 | 2021 | 2788 | 0.150 |
Why?
|
| Peritoneal Cavity | 1 | 2017 | 148 | 0.150 |
Why?
|
| Cardiology | 2 | 2020 | 1668 | 0.150 |
Why?
|
| Pulmonary Valve | 2 | 2004 | 437 | 0.140 |
Why?
|
| Vocal Cord Paralysis | 1 | 2020 | 267 | 0.140 |
Why?
|
| Propensity Score | 3 | 2021 | 1781 | 0.140 |
Why?
|
| Models, Statistical | 5 | 2020 | 5102 | 0.140 |
Why?
|
| Collateral Circulation | 1 | 2017 | 287 | 0.140 |
Why?
|
| California | 1 | 2020 | 1402 | 0.140 |
Why?
|
| Infusions, Intravenous | 4 | 2010 | 2274 | 0.140 |
Why?
|
| Age Factors | 8 | 2020 | 18370 | 0.140 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 426 | 0.140 |
Why?
|
| Macrophage-1 Antigen | 1 | 2017 | 290 | 0.140 |
Why?
|
| Hospital Charges | 2 | 2015 | 362 | 0.140 |
Why?
|
| Platelet Function Tests | 1 | 2017 | 270 | 0.130 |
Why?
|
| Myocardial Contraction | 3 | 2016 | 1585 | 0.130 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2017 | 378 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1107 | 0.130 |
Why?
|
| Career Choice | 1 | 2022 | 744 | 0.130 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1996 | 187 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 345 | 0.130 |
Why?
|
| Aprotinin | 1 | 2015 | 88 | 0.130 |
Why?
|
| Respiration Disorders | 1 | 2018 | 371 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 10943 | 0.130 |
Why?
|
| Neonatal Screening | 1 | 2019 | 591 | 0.130 |
Why?
|
| Predictive Value of Tests | 8 | 2020 | 15076 | 0.130 |
Why?
|
| Monitoring, Physiologic | 4 | 2019 | 1738 | 0.130 |
Why?
|
| Anesthetics, Intravenous | 1 | 2018 | 417 | 0.130 |
Why?
|
| Child Nutrition Disorders | 1 | 1996 | 149 | 0.130 |
Why?
|
| Comorbidity | 5 | 2020 | 10388 | 0.120 |
Why?
|
| Brain | 5 | 2020 | 26385 | 0.120 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 642 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 2018 | 767 | 0.120 |
Why?
|
| Propanolamines | 1 | 1995 | 167 | 0.120 |
Why?
|
| Fibrinolysis | 1 | 2015 | 322 | 0.120 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39050 | 0.120 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 440 | 0.120 |
Why?
|
| Physical Examination | 1 | 2020 | 1237 | 0.120 |
Why?
|
| Current Procedural Terminology | 1 | 2014 | 92 | 0.120 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 1364 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2017 | 594 | 0.110 |
Why?
|
| Hemodilution | 2 | 2010 | 114 | 0.110 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 373 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2021 | 880 | 0.110 |
Why?
|
| Aortic Valve | 3 | 2004 | 1922 | 0.110 |
Why?
|
| Adolescent Behavior | 1 | 2001 | 1151 | 0.110 |
Why?
|
| Logistic Models | 7 | 2018 | 13408 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2016 | 535 | 0.110 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 1440 | 0.110 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 12245 | 0.110 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2018 | 591 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 4 | 2019 | 1965 | 0.110 |
Why?
|
| Boston | 4 | 2018 | 9313 | 0.110 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2012 | 34 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 2012 | 141 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 941 | 0.100 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 1956 | 0.100 |
Why?
|
| Premedication | 2 | 2012 | 258 | 0.100 |
Why?
|
| Liver | 1 | 2007 | 7474 | 0.100 |
Why?
|
| Embryonic Development | 1 | 2016 | 711 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1177 | 0.100 |
Why?
|
| Mammary Arteries | 1 | 1991 | 70 | 0.100 |
Why?
|
| Growth Disorders | 1 | 1996 | 645 | 0.100 |
Why?
|
| Myocardial Ischemia | 2 | 2008 | 2148 | 0.100 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2012 | 238 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2016 | 764 | 0.100 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1991 | 177 | 0.100 |
Why?
|
| Hospitals | 3 | 2023 | 3952 | 0.090 |
Why?
|
| Prospective Studies | 15 | 2019 | 53288 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2022 | 9146 | 0.090 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 1525 | 0.090 |
Why?
|
| Extremities | 1 | 2016 | 865 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 770 | 0.090 |
Why?
|
| Vascular Resistance | 3 | 2019 | 936 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 840 | 0.090 |
Why?
|
| Anesthesia, Inhalation | 2 | 1992 | 223 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2132 | 0.090 |
Why?
|
| Collagen Type VIII | 1 | 2009 | 15 | 0.090 |
Why?
|
| Odds Ratio | 4 | 2016 | 9849 | 0.090 |
Why?
|
| Nursing Records | 1 | 2009 | 28 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 514 | 0.090 |
Why?
|
| Heparin Antagonists | 1 | 2009 | 32 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 996 | 0.090 |
Why?
|
| Triiodothyronine | 2 | 2016 | 494 | 0.090 |
Why?
|
| Prognosis | 4 | 2021 | 29063 | 0.090 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 1076 | 0.080 |
Why?
|
| Cohort Studies | 7 | 2020 | 40561 | 0.080 |
Why?
|
| Young Adult | 7 | 2023 | 56430 | 0.080 |
Why?
|
| Klinefelter Syndrome | 1 | 2009 | 48 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1995 | 1240 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 19905 | 0.080 |
Why?
|
| Time Factors | 8 | 2020 | 40075 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2001 | 3966 | 0.080 |
Why?
|
| Nervous System Malformations | 1 | 2010 | 247 | 0.080 |
Why?
|
| Patient Participation | 1 | 2018 | 1457 | 0.080 |
Why?
|
| Language | 1 | 2018 | 1471 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1312 | 0.080 |
Why?
|
| Saphenous Vein | 1 | 1991 | 532 | 0.080 |
Why?
|
| Blood Pressure | 4 | 2016 | 8554 | 0.080 |
Why?
|
| Platelet Count | 2 | 2009 | 781 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2212 | 0.080 |
Why?
|
| Anesthesia Recovery Period | 2 | 2008 | 157 | 0.080 |
Why?
|
| Echocardiography, Doppler | 2 | 2008 | 935 | 0.080 |
Why?
|
| Catheterization | 1 | 1994 | 1470 | 0.080 |
Why?
|
| Platelet Factor 4 | 1 | 2008 | 129 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 425 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 1239 | 0.080 |
Why?
|
| Blood Volume | 1 | 2009 | 565 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2018 | 8324 | 0.080 |
Why?
|
| Pentobarbital | 1 | 2008 | 155 | 0.080 |
Why?
|
| Arachidonic Acid | 1 | 2009 | 434 | 0.080 |
Why?
|
| Body Weight | 2 | 2017 | 4669 | 0.080 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 440 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 1150 | 0.080 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2012 | 793 | 0.070 |
Why?
|
| Psychomotor Agitation | 1 | 2009 | 293 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2020 | 5985 | 0.070 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2007 | 114 | 0.070 |
Why?
|
| Motivation | 1 | 2016 | 1971 | 0.070 |
Why?
|
| Sepsis | 2 | 2019 | 2593 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2020 | 2758 | 0.070 |
Why?
|
| Craniotomy | 1 | 2010 | 729 | 0.070 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2007 | 194 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2023 | 7279 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2023 | 4468 | 0.070 |
Why?
|
| Postoperative Care | 3 | 2022 | 1486 | 0.070 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 3674 | 0.070 |
Why?
|
| Blood Coagulation Disorders | 1 | 2009 | 337 | 0.070 |
Why?
|
| Patient Selection | 1 | 2018 | 4215 | 0.070 |
Why?
|
| Capnography | 1 | 2006 | 89 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 1994 | 1486 | 0.070 |
Why?
|
| Anesthesia, Epidural | 1 | 1988 | 228 | 0.070 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 376 | 0.070 |
Why?
|
| ROC Curve | 3 | 2018 | 3527 | 0.070 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 419 | 0.060 |
Why?
|
| Aspirin | 1 | 2017 | 3282 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2009 | 1472 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2018 | 3679 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2008 | 881 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 686 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2010 | 680 | 0.060 |
Why?
|
| Child Behavior | 1 | 2010 | 839 | 0.060 |
Why?
|
| Risk | 1 | 2017 | 9687 | 0.060 |
Why?
|
| Calcium | 1 | 1997 | 5756 | 0.060 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2007 | 440 | 0.060 |
Why?
|
| Ethers | 2 | 1995 | 75 | 0.060 |
Why?
|
| Anxiety | 1 | 2018 | 4297 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2009 | 569 | 0.060 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2004 | 183 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2008 | 1402 | 0.060 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 1236 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 3670 | 0.060 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2005 | 488 | 0.060 |
Why?
|
| Massachusetts | 1 | 2016 | 8663 | 0.060 |
Why?
|
| Vasodilation | 1 | 2007 | 944 | 0.060 |
Why?
|
| Aneurysm | 1 | 1986 | 339 | 0.060 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15165 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5137 | 0.060 |
Why?
|
| Myocardium | 1 | 2016 | 4776 | 0.060 |
Why?
|
| Blood Coagulation Tests | 2 | 2017 | 263 | 0.050 |
Why?
|
| Heart Rate | 2 | 2016 | 4091 | 0.050 |
Why?
|
| Anesthesia, Intravenous | 1 | 2003 | 130 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 834 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2004 | 275 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Methyl Ethers | 2 | 1995 | 205 | 0.050 |
Why?
|
| Ebstein Anomaly | 1 | 2003 | 97 | 0.050 |
Why?
|
| Oxygenators | 1 | 2021 | 34 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 7913 | 0.050 |
Why?
|
| Middle Aged | 11 | 2021 | 213383 | 0.050 |
Why?
|
| Heart Atria | 1 | 2008 | 1357 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2022 | 5788 | 0.050 |
Why?
|
| Criminal Law | 1 | 2001 | 96 | 0.050 |
Why?
|
| Alprostadil | 1 | 2021 | 89 | 0.050 |
Why?
|
| Angiography | 1 | 2007 | 1639 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14722 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2001 | 218 | 0.050 |
Why?
|
| Aorta, Thoracic | 2 | 2023 | 1082 | 0.050 |
Why?
|
| Xenon | 1 | 2021 | 110 | 0.050 |
Why?
|
| Ligation | 1 | 2021 | 453 | 0.050 |
Why?
|
| Quality of Life | 1 | 2022 | 12804 | 0.050 |
Why?
|
| Tuberous Sclerosis | 1 | 2009 | 1029 | 0.050 |
Why?
|
| Endoscopy | 1 | 2010 | 1785 | 0.050 |
Why?
|
| Animals | 5 | 2021 | 168757 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2001 | 623 | 0.050 |
Why?
|
| Pediatric Nursing | 2 | 2002 | 103 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6538 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2001 | 202 | 0.040 |
Why?
|
| Radiography | 3 | 2010 | 7023 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1850 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 2000 | 143 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2004 | 581 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2002 | 374 | 0.040 |
Why?
|
| Radiology, Interventional | 1 | 2002 | 460 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6196 | 0.040 |
Why?
|
| Drug Dosage Calculations | 1 | 2019 | 114 | 0.040 |
Why?
|
| Hypotension | 1 | 2004 | 884 | 0.040 |
Why?
|
| American Heart Association | 1 | 2022 | 1056 | 0.040 |
Why?
|
| Sternum | 1 | 2018 | 177 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2008 | 1139 | 0.040 |
Why?
|
| Aged | 6 | 2021 | 163280 | 0.040 |
Why?
|
| Morphine | 1 | 2021 | 657 | 0.040 |
Why?
|
| Ventricular Septum | 1 | 2017 | 73 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3508 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2376 | 0.040 |
Why?
|
| Child Nutrition Sciences | 1 | 1996 | 23 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 1985 | 1071 | 0.040 |
Why?
|
| Noble Gases | 1 | 2016 | 18 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2020 | 1308 | 0.040 |
Why?
|
| Airway Management | 1 | 2020 | 329 | 0.040 |
Why?
|
| Ketamine | 1 | 2002 | 500 | 0.040 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2016 | 62 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2021 | 21746 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5615 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2020 | 1654 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1105 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10252 | 0.030 |
Why?
|
| Aorta | 1 | 2023 | 2061 | 0.030 |
Why?
|
| Angiotensin II | 1 | 1979 | 881 | 0.030 |
Why?
|
| Critical Illness | 2 | 2020 | 2670 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2016 | 198 | 0.030 |
Why?
|
| Hand | 1 | 2021 | 884 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57776 | 0.030 |
Why?
|
| Breath Tests | 1 | 2016 | 280 | 0.030 |
Why?
|
| Catecholamines | 1 | 2016 | 387 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2017 | 319 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
| Communication Barriers | 1 | 2018 | 398 | 0.030 |
Why?
|
| Propofol | 1 | 2021 | 629 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 390 | 0.030 |
Why?
|
| Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
| Antiemetics | 1 | 2016 | 177 | 0.030 |
Why?
|
| Relative Value Scales | 1 | 2014 | 84 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Veins | 1 | 2018 | 770 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 798 | 0.030 |
Why?
|
| Hematinics | 1 | 2016 | 281 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2020 | 761 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 1996 | 723 | 0.030 |
Why?
|
| Infection Control | 1 | 2020 | 966 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 2014 | 455 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2886 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1411 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1199 | 0.030 |
Why?
|
| Dantrolene | 1 | 1991 | 26 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1477 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2017 | 1539 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2016 | 1133 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2006 | 12026 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1995 | 579 | 0.020 |
Why?
|
| Malignant Hyperthermia | 1 | 1991 | 73 | 0.020 |
Why?
|
| Aging | 1 | 2010 | 8664 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1991 | 301 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2017 | 1086 | 0.020 |
Why?
|
| Hemosiderin | 1 | 2010 | 43 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4933 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 1995 | 2124 | 0.020 |
Why?
|
| Models, Economic | 1 | 2014 | 713 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 1994 | 1423 | 0.020 |
Why?
|
| Patient Admission | 1 | 2017 | 1380 | 0.020 |
Why?
|
| Respiration | 1 | 2016 | 1653 | 0.020 |
Why?
|
| Psychomotor Disorders | 1 | 2010 | 152 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1991 | 909 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 13881 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1261 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5917 | 0.020 |
Why?
|
| Epinephrine | 1 | 1991 | 792 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2002 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2864 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 8863 | 0.020 |
Why?
|
| Decision Making | 1 | 2001 | 3887 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6473 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 1991 | 841 | 0.020 |
Why?
|
| Pancuronium | 1 | 1986 | 45 | 0.020 |
Why?
|
| Random Allocation | 1 | 1991 | 2429 | 0.020 |
Why?
|
| Thiopental | 1 | 1986 | 59 | 0.020 |
Why?
|
| Stents | 1 | 2019 | 3280 | 0.020 |
Why?
|
| Factor VIII | 1 | 2009 | 347 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2951 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 722 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8301 | 0.020 |
Why?
|
| Prevalence | 1 | 2001 | 15226 | 0.020 |
Why?
|
| Central Nervous System Diseases | 1 | 2009 | 518 | 0.020 |
Why?
|
| Oscillometry | 1 | 1984 | 147 | 0.020 |
Why?
|
| Mathematics | 1 | 1985 | 728 | 0.010 |
Why?
|
| Thoracic Injuries | 1 | 1986 | 272 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1988 | 977 | 0.010 |
Why?
|
| Factor X | 1 | 2003 | 64 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6365 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1996 | 3528 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 987 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 152 | 0.010 |
Why?
|
| Antithrombin III | 1 | 2003 | 128 | 0.010 |
Why?
|
| Organization and Administration | 1 | 2002 | 52 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2007 | 591 | 0.010 |
Why?
|
| Protein C | 1 | 2003 | 138 | 0.010 |
Why?
|
| Factor VII | 1 | 2003 | 139 | 0.010 |
Why?
|
| Prothrombin | 1 | 2003 | 185 | 0.010 |
Why?
|
| Factor V | 1 | 2003 | 178 | 0.010 |
Why?
|
| Nursing Assessment | 1 | 2002 | 107 | 0.010 |
Why?
|
| Perfusion | 1 | 2007 | 1360 | 0.010 |
Why?
|
| Credentialing | 1 | 2002 | 126 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7322 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14557 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 1456 | 0.010 |
Why?
|
| Probability | 1 | 2007 | 2505 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 552 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5952 | 0.010 |
Why?
|
| Saralasin | 1 | 1979 | 39 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 24260 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2002 | 469 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2000 | 520 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
| Hypertension, Renovascular | 1 | 1979 | 123 | 0.010 |
Why?
|
| Radiology Department, Hospital | 1 | 2002 | 412 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18029 | 0.010 |
Why?
|
| Renin | 1 | 1979 | 642 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 1681 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4982 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2009 | 4371 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 8089 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 1991 | 78 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2002 | 2531 | 0.010 |
Why?
|
| Nausea | 1 | 1992 | 673 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1979 | 12959 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1986 | 20129 | 0.000 |
Why?
|